Clin Pediatr Hematol Oncol.  2006 Apr;13(1):46-54.

Differentiation of Endothelial Progenitor Cells from Cord Blood by Ex Vivo Expansion

Affiliations
  • 1Department of Pediatrics, Ewha Womans University College of Medicine, Seoul, Korea. eunsyoo@ewha.ac.kr

Abstract

PURPOSE: Endothelial progenitor cells (EPCs) play a significant role in neovascularization of ischemic tissues and in re-endothelialization of injured blood vessels and hold promise for therapeutic neovascularization. The purpose of this study was to study the differentiation of EPCs from human cord blood (CB) mononeuclear cells (MNCs) during in vitro expansion.
METHODS
Cord blood was collected from 5 normal full-term babies and MNCs were isolated. 1 x 10(8) MNCs were plated on a 100 mm culture dish coated with 50 ug/ml of human fibronectin (Calbiochem) and cultured in EGM-2 BulletKit system (Clonetics). Endothelial outgrowing cells were assessed by morphology, flow cytometry, immunohistochemistry, RT-PCR and in vitro tube formation in Matrigel plate.
RESULTS
Spindle-shaped cells which were grown at the first week of culture were positive for VEGFR-2 and CD31, and negative for vWF, VE-Cadherin. Cobblestone shaped cells which were grown at the third week of culture were positive for VEGFR-2, VE-Cadherin, vWF and VE-Cadherin. Cultured cells expressed high level of mRNA of VEGFR-2, vWF and VE-Cadherin and also formed capillary tubes on Matrigel plates.
CONCLUSION
We provide evidence that EPCs in human cord blood differentiate into functional endothelial cells. Under the situation of increasing allogeneic transplantation using CB, these differentiated cells could provide potential clinical applications for "cell therapy" in the situation of vascular injuries (ie, hindlimb ischemia and myocardial infacrtion), because of the large number of EPCs in addition to their homing capacity to the vascularization site.

Keyword

Endothelial progenitor cell; Cord blood ex vivo expansion; Therapeutic vasculogenesis

MeSH Terms

Animals
Blood Vessels
Capillaries
Cells, Cultured
Endothelial Cells
Fetal Blood*
Fibronectins
Flow Cytometry
Hindlimb
Humans
Immunohistochemistry
Ischemia
RNA, Messenger
Stem Cells*
Transplantation, Homologous
Vascular Endothelial Growth Factor Receptor-2
Vascular System Injuries
Fibronectins
RNA, Messenger
Vascular Endothelial Growth Factor Receptor-2
Full Text Links
  • CPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr